BIOHENG

BioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2017, Bioheng has established a high standard GMP grade clinical translational center, and is leading in the field of cell engineering, proliferation and clinical applications. Particularly, Bioheng owns several cutting-edge patents plus extensive industry experience, and has built a complete, closed an... d automated production system in compliance with regulatory guidelines. In 2018, Bioheng has successfully raised tens of millions of RMB seeding fund from Simcere Pharmaceutical Group, aiming to accelerate the development of immunotherapy via integrating resources from both parties. Bioheng is dedicated to develop safer, effective and less expensive cell therapy drugs to benefit more patients.

#SimilarOrganizations #People #Financial #Website #More

BIOHENG

Industry:

Biopharma Biotechnology Clinical Trials Health Care Innovation Management

Founded:

2017-01-01

Address:

Nanjing, Jiangsu, China

Country:

China

Website Url:

http://www.bioheng.com

Total Employee:

Status:

Active

Contact:

400-828-8076

Email Addresses:

[email protected]

Total Funding:

620 M CNY

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Apple Mobile Web App Capable JQuery CDN Apple Mobile Web App Status Bar Style Cart Functionality HiChina DNS